Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 28:8:327.
doi: 10.1186/1743-422X-8-327.

Active hepatitis C infection and HCV genotypes prevalent among the IDUs of Khyber Pakhtunkhwa

Affiliations

Active hepatitis C infection and HCV genotypes prevalent among the IDUs of Khyber Pakhtunkhwa

Latif ur Rehman et al. Virol J. .

Abstract

Injection drug users (IDUs) are considered as a high risk group to develop hepatitis C due to needle sharing. In this study we have examined 200 injection drug users from various regions of the Khyber Pakhtunkhwa province for the prevalence of active HCV infection and HCV genotypes by Immunochromatographic assays, RT-PCR and Type-specific PCR. Our results indicated that 24% of the IDUs were actively infected with HCV while anti HCV was detected among 31.5% cases. Prevalent HCV genotypes were HCV 2a, 3a, 4 and 1a. Majority of the IDUs were married and had attained primary or middle school education. 95% of the IDUs had a previous history of needle sharing. Our study indicates that the rate of active HCV infection among the IDUs is higher with comparatively more prevalence of the rarely found HCV types in KPK. The predominant mode of HCV transmission turned out to be needle sharing among the IDUs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gel photograph of HCV PCR products: Lane 1 shows 100 bp DNA ladder, lane 2, and 3 are the positive samples for active HCV infection showing 285 bp nested PCR product, Lane 4 is positive HCV control while Lane 5 is negative control.

Similar articles

Cited by

References

    1. Ryan KJ, Ray CG. Sherris Medical Microbiology. New York: McGraw Hill; 2004. pp. 551–2.
    1. Rizzetto M. In: Oxford Textbook of Clinical Hepatology. McIntyre N, Benhamou JP, Bicher J, Rizzeto M, Rodes J, editor. Oxford Medical Publication; 1992. Viral hepatitis: introduction; p. 529.
    1. Lo Re V, Kostman JR. Management of chronic hepatitis C. Postgrad Med J. 2005;81:376–82. doi: 10.1136/pgmj.2004.025403. - DOI - PMC - PubMed
    1. WHO. Hepatitis C: Fact sheet No. 164. Geneva;
    1. Takahashi M, Yamada G, Miyamato R, Doi TEndo, Tsuji T. Natural course of chronic hepatitis C. American J Gastroenterology. 1993;88:240–243. - PubMed